Outlines the 2007 AACVPR/ACC/AHA performance measures and discharge checklist for cardiac rehabilitation referral and secondary prevention.
Answers are grounded in this paper and cite their sources.
Promotes consistent cardiac rehabilitation referral at discharge; extends secondary prevention guidelines into measurable performance standards.
Check each therapy prescribed or check contraindication reason. Aspirin: next dose due (date/time)____________/____________ No aspirin, reason documented in discharge summary. Clopidogrel: next dose due (date/time)____________/____________ No clopidogrel, reason documented in discharge summary. Beta blocker: next dose due (date/time)____________/____________ No beta blocker, reason in discharge summary. ACE inhibitor: next dose due (date/time)____________/____________ No ACE inhibitor, reason documented in discharge summary. Statin or other lipid-lowering agent (LLA): next dose due (date/time)_________/__________ No statin or other LLA, reason documented in discharge summary. Cardiac rehabilitation referral made, patient information communicated to program, and program information/appointment communicated to patient No exercise prescription and/or cardiac rehabilitation referral with reason in discharge summary. Smoking cessation teaching and pharmacological therapy given (patient is a current smoker or former smoker of less than 1 year) or Smoking cessation teaching and pharmacological therapy not required (patient is nonsmoker or former smoker of greater than 1 year). Education on warning signs of MI and what to do if symptoms given. Education not given, reason documented in discharge summary. Diet: low-fat, low-cholesterol, no added salt ______________________________________ Follow-up appointment documented in medical record.
No takes yet. Share an insight, caveat, or question.
Thomas et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: